Digital DNA Enables the Real-World Evidence Ecosystem to Improve Patient Outcomes

Cultivating Digital DNA (Data, Networks, and Applications) Enables a Thriving Real-World Evidence Ecosystem to Improve Patient Outcomes

An evolution of medical diagnostics, treatments, and services relies upon a multitude of trusted vendors collectively developing “Digital DNA” — scaled medical datasets, diverse provider networks, and cutting-edge software applications.

by Allison Robbins, CFA* | David M. Rubin, PhD | Junko Saber, MBA | Arash Hanifi, PhD

*corresponding author: arobbins@greenshootsconsults.com

Digital DNA Enables the Real-World Evidence Ecosystem to Improve Patient Outcomes 2021-10-25T19:09:59+00:00

Radar On – December 2018: HHS Proposal Could Reduce Costs but May Harm Patient Care

Radar On – December 2018: HHS Proposal Could Reduce Costs but May Harm Patient Care

“If the proposed changes to the protected classes are implemented, “the effect on patients and prescribers will be greater delay, less choice or options and more administrative/time costs to secure the treatments that are best for them individually,”

–Lisa Kennedy

 

Radar On – December 2018: HHS Proposal Could Reduce Costs but May Harm Patient Care 2019-01-02T22:22:45+00:00

Radar On – October 2018: HHS Wants to See WACs in TV Ads

Radar On – October 2018: HHS Wants to See WACs in TV Ads

“Transparency in the prices of health care services is always a good thing — but finding the prices of drugs is generally easier for patients to find than other health care services that they get. More importantly, what patients are most interested in is what they personally will pay, and this ruling does not help them.” –Lisa Kennedy

 

Radar On – October 2018: HHS Wants to See WACs in TV Ads 2019-01-02T22:23:21+00:00

Radar On – September 2018: CVS Will Exclude Certain Drugs Based on ICER Analyses of QALY

Radar On – September 2018: CVS Will Exclude Certain Drugs Based on ICER Analyses of QALY

“The question is how this will affect innovative drugs where there are fewer alternatives for patients. Any decision to use this approach needs to also be carefully evaluated in the context of how it could help or harm patients, which I’m sure CVS will do.…I can’t see a lot of benefits to this approach.”
–Lisa Kennedy

 

Radar On – September 2018: CVS Will Exclude Certain Drugs Based on ICER Analyses of QALY 2019-01-02T22:24:26+00:00

From First to Last

“Only 68% of women get mammography and we know that this is much lower in Wyoming. We look to change this by bringing mammography straight to your doorstep so you don’t have to travel long distances. – Lisa Kennedy, Changing the state of women’s health in Wyoming

From First to Last 2018-05-29T21:29:20+00:00

Treating the Individual: Personalized Medicine in the Community

“You have 30,000 women diagnosed with triple negative cancer every year in the US. Triple negative cancer is defined by what it isn’t and all we have to treat these cancers really is chemotherapy. There are no targeted treatments that women of color with this disease have today. With everything we know about the human genome – that cure is within our grasp – it’s not just leaving it to the scientists – it’s really bringing a community of women- multicultural women – to help us solve this very big problem. -Lisa Kennedy

Treating the Individual: Personalized Medicine in the Community 2018-11-06T20:23:17+00:00